JPRN-UMIN000021987已完成未知
Effect of Once-Weekly Teriparatide for Bisphosphonate-Resisitance Glucocorticoid-Induced Osteoporosis (TeriGo) - Effect of Once-Weekly Teriparatide for Bisphosphonate-Resisitance Glucocorticoid-Induced Osteoporosis (TeriGo)
Teikyo University School of Medicine (Hajime Kono) Toho University School of Medicine (Toshihiro Nanki)0 个研究点目标入组 150 人开始时间: 2016年4月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients whose BMD of 3 or more of lumbar spines cannot be analysed because of fracture or artificial materials. 2) Contraindication for bisphosphonate or teriparatide. 3) Patients who have received teriparatide or denosumab. 4) Patients with active infection or malignancy. 5) Age less than 20 years old. 6) Patients who is currently pregnant, breastfeeding or willing to get pregnant. 7) Patients who do not give consent to the study. 8) Patients who are judged to be inappropriate by the physician.
研究者
相似试验
招募中
Unknown
Safety and efficacy of twice-weekly teriparatide in hemodialysis patients with osteoporosisChronic Kidney DiseaseJPRN-jRCTs011230047ishio Saori50
已完成
不适用
Efficacy of once weekly teriparatide in patients with glucocorticoid-induced osteoporosisJPRN-UMIN000011419Glucocorticoid-induced osteoporosis research group204
已完成
不适用
TeriGo StudyJPRN-jRCTs031180311anki Toshihiro44
尚未招募
不适用
Bisphosphonate therapy in idiopathic avascular necrosis of femoral head in adolescents and young adults.CTRI/2022/10/046412Department of Orthopedics40
已完成
不适用
Effect of once-weekly teriparatide for bone metabolism in praimary osteoprosis patients.JPRN-UMIN000032090Kindai University Hospital Department of Orthopaedic surgery50